Skip to content
Screener

Penumbra PEN Q1 2026 earnings

Reported May 6, 2026 · Before market open

Revenue$374.8MBeat by $4.3M
EPS$0.82Miss by $0.24
Revenue estimate$370.5M
EPS estimate$1.06

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$401.4M
EPS estimate$1.20

Financials

Q1 2026

Income statement

See full
Revenue$374.8M+15.6%
Gross profit$253.4M+17.4%
Operating income$38.2M-5.2%
Net income$32.6M-16.9%
EPS (diluted)$0.82-18.0%

Balance sheet

See full
Cash & equivalents$241.3M-35.8%
Total debt$216.2M-2.0%
Total equity$1.5B+21.5%
Total assets$1.9B+19.2%

Cash flow

See full
Operating cash flow$87.0M+77.6%
CapEx$13.7M+1.5%
Free cash flow$73.3M+106%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$12.89B+25.1%
Enterprise value$12.86B+26.8%
P/E75.3×-169×
P/S8.9×+0.6×

Profitability

See full
Gross margin67.4%+3.7pp
Operating margin12.9%+9.8pp
Net margin11.8%+8.4pp
FCF margin14.6%+2.5pp

Returns & leverage

See full
Return on equity12.7%+9.2pp
Debt / equity0.1×0.0×
Current ratio6×-0.3×

Segments

By product

See full
Thrombectomy$253.9M+12.1%
Embolization and Access$120.8M+23.8%

FAQ

When did Penumbra report Q1 2026 earnings?
Penumbra (PEN) reported Q1 2026 earnings on May 6, 2026 before market open.
What were Penumbra's Q1 2026 revenue and EPS?
Penumbra reported revenue of $374.8M and eps of $0.82 for Q1 2026.
Did Penumbra beat estimates in Q1 2026?
Revenue beat the consensus estimate of $370.5M by $4.3M. EPS missed the consensus estimate of $1.06 by $0.24.
How did Penumbra's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 15.6% from $324.1M a year earlier and eps declined 1.2% from $0.83.
Where can I find Penumbra's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001321732-26-000018) and the 10-Q periodic report (0001321732-26-000019) directly on SEC EDGAR. The filing index links above go to sec.gov.